Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) where stereochemistry plays a critical role in biological activity. Its structure, featuring a trifluoromethyl group adjacent to a chiral alcohol, makes it valuable in optimizing metabolic stability and binding affinity in drug candidates. Commonly employed in the production of central nervous system agents, anti-inflammatory compounds, and agrochemicals requiring high enantiomeric purity. Also utilized in asymmetric synthesis and catalysis research due to its ability to induce stereoselectivity in complex transformations.